These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7048656)

  • 21. Fansidar resistant Plasmodium falciparum infection in Surinam.
    Oostburg BF; Jozefzoon LM
    Trop Geogr Med; 1983 Sep; 35(3):243-7. PubMed ID: 6359597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of malaria prophylaxis in American and Swiss travelers to Kenya.
    Lobel HO; Roberts JM; Somaini B; Steffen R
    J Infect Dis; 1987 Jun; 155(6):1205-9. PubMed ID: 3553347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fansidar resistance in the Philippines.
    Watt G; Padre LP; Tuazon LR; Laughlin LW
    Trans R Soc Trop Med Hyg; 1987; 81(3):521. PubMed ID: 3318028
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis.
    Win K; Thwe Y; Lwin TT; Win K
    Lancet; 1985 Sep; 2(8457):694-5. PubMed ID: 2863679
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected.
    Kilimali VA; Mkufya AR
    Trans R Soc Trop Med Hyg; 1985; 79(4):482-3. PubMed ID: 3909553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fansidar resistant falciparum malaria acquired in South East Asia.
    Black F; Bygbjerg I; Effersøe P; Gomme G; Jepsen S; Jensen GA
    Trans R Soc Trop Med Hyg; 1981; 75(5):715-6. PubMed ID: 7036431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.
    Schapira A; Bygbjerg IC; Jepsen S; Flachs H; Bentzon MW
    Am J Trop Med Hyg; 1986 Mar; 35(2):239-45. PubMed ID: 3513641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial of fansimef in Indian patients of P. falciparum malaria.
    Asthana OP; Tangri AN; Nityanand S
    Indian J Malariol; 1988 Dec; 25(2):89-96. PubMed ID: 3077373
    [No Abstract]   [Full Text] [Related]  

  • 30. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar.
    Dixon KE; Williams RG; Pongsupat T; Pitaktong U; Phintuyothin P
    Trans R Soc Trop Med Hyg; 1982; 76(5):664-7. PubMed ID: 6758224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Falciparum malaria resistant to chloroquine and Fansidar.
    Jaatinen M; Kihamia CM; McLarty DG
    Br Med J (Clin Res Ed); 1984 Jan; 288(6410):65. PubMed ID: 6418318
    [No Abstract]   [Full Text] [Related]  

  • 33. Indications for the use of Fansidar in malaria.
    Schwartz IK; Campbell CC
    N Engl J Med; 1982 Jul; 307(3):194. PubMed ID: 7088068
    [No Abstract]   [Full Text] [Related]  

  • 34. Fansidar in malaria prophylaxis.
    Bradley DJ; Hall AP; Peters W; Warhurst D
    Br Med J (Clin Res Ed); 1985 Jul; 291(6488):136. PubMed ID: 3926082
    [No Abstract]   [Full Text] [Related]  

  • 35. The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria.
    Olatunde A; Salako LA; Walker O
    Trans R Soc Trop Med Hyg; 1981; 75(6):848-50. PubMed ID: 7036438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Problems encountered with using Fansidar as prophylaxis for malaria.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 May; 31(17):232-4. PubMed ID: 6804785
    [No Abstract]   [Full Text] [Related]  

  • 37. Fansidar for malaria prophylaxis.
    Kissane D
    Aust Fam Physician; 1985 Aug; 14(8):738. PubMed ID: 3901990
    [No Abstract]   [Full Text] [Related]  

  • 38. Falciparum malaria resistant to chloroquine and Fansidar: implications for prophylaxis.
    Eyre SJ
    Br Med J (Clin Res Ed); 1984 Feb; 288(6417):644. PubMed ID: 6421416
    [No Abstract]   [Full Text] [Related]  

  • 39. Ineffective malaria prophylaxis.
    Sinclair N; Sharp P; Davis S
    Med J Aust; 1982 Feb; 1(4):151-3. PubMed ID: 7043217
    [No Abstract]   [Full Text] [Related]  

  • 40. [Malaria in pregnant women--native inhabitants of the Congo--and its treatment using quinimax and fansidar].
    Splavskiĭ OI
    Med Parazitol (Mosk); 1986; (5):49-51. PubMed ID: 3540557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.